MABION SA ZY -,10

Share · PLMBION00016 · A1J13Q (XWAR)

Overview

No Price

Closing Price XWAR 06.03.2026: 8,05 PLN

06.03.2026 16:00

Current Prices from MABION SA ZY -,10

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
WSE	MAB.WA	PLN	06.03.2026 16:00	8,05 PLN	-0,010 PLN -0,12 %
Frankfurt	272.F	EUR	27.02.2026 07:05	1,89 EUR	-

Share Float & Liquidity

Free Float 63,70 %

Shares Float 10,3 M

Shares Outstanding 16,16 M

Company Profile for MABION SA ZY -,10 Share

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.

AI Analysis of MABION SA ZY -,10

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of MABION SA ZY -,10

No AI threads available for this company yet.

Company Data

Name MABION SA ZY -,10

Company Mabion S.A.

Website https://www.mabion.eu

Primary Exchange

WSE

WKN A1J13Q

ISIN PLMBION00016

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Krzysztof Kaczmarczyk

Market Capitalization 130 Mio

Country Poland

Currency EUR

Employees 0,2 T

Address ul. gen. Mariana Langiewicza 60, 95-050 Konstantynów Lódzki

IPO Date 2010-08-10

Ticker Symbols

Name	Symbol
Frankfurt	272.F
WSE	MAB.WA

More Shares

Investors who hold MABION SA ZY -,10 also have the following shares in their portfolio:

PRUDENTIAL FINL 2047 Bond

WELLS FARGO 20/30 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog